Stockwatch: Runners And Riders In The Coronavirus Stakes
Generalist Investors Among Possible Losers In The Pandemic
With so many companies developing treatments and vaccines against coronavirus, and most other affected by the pandemic, they can’t all be winners.
You may also be interested in...
Coronavirus Update: After 'Warp Speed' Snub, Novavax Awarded US Military Vaccine Deal
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
Coronavirus Update: White House Picks Five Vaccines For US Operation Warp Speed
An official announcement is expected within weeks, as competition between US and China stokes fears of 'vaccine nationalism'.
Stock Watch: Defeat Is The Mother Of Reinvention
Companies that are successful do not need to change their name, therapeutic area or product focus.